Global Immunotherapy Markets, 2021-2027: Growth Drivers Include Increasing Prevalence of Auto-Immune Diseases in Adults and Increasing Investments in Research and Funding of Cancer

Key Facts

The global Immunotherapy market is projected to grow at a significant CAGR of 13.8% during the forecast period, 2021-2027 The major factors that are augmenting the growth of the immunotherapy market include the increasing prevalence of auto-immune diseases among adults and the increasing investments in research and funding of cancer.
For instance, in July 2021 The Cancer Research Institute (CRI), one of the US nonprofit organizations which are work in the discovery, and development of powerful immunotherapies for all cancers, was announced that it was awarded more than $28.5 million in research grants and fellowships during the 2021 fiscal year ending June 30, 2021.
Technological development is also estimated to be the prime factor that is contributing significantly towards the growth of the market, such as the real-time, noninvasive visualization of specific cells, or the application of artificial intelligence (AI) to pathology, which have garnered recent attention in the immunotherapy market.
However, the high treatment costs and low purchasing power of consumers are expected to hamper the growth of the global immunotherapy market.